Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts

In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts

US Patent 8679511 · Granted Mar 25, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination hormone replacement therapy (HRT) and melatonin to prevent and treat2016
Anti-cancer tamoxifen-melatonin hybrid ligand2014
Combination hormone replacement therapy (HRT) and melatonin to prevent and treat2013